Routine

Viral warts & molluscum contagiosum

warts, verruca, common wart, plantar wart, verruca vulgaris, HPV, molluscum contagiosum, anogenital warts, condylomata acuminata · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Benign viral skin infections. Cutaneous warts (HPV) are common in children/young adults and usually self-resolve over months-years. Molluscum contagiosum (poxvirus) causes umbilicated papules, common in children and in sexually active or immunosuppressed adults. Both are benign and self-limiting in the immunocompetent; extensive/atypical disease should prompt consideration of immunosuppression. Anogenital warts and genital molluscum warrant STI screening.

Red flags

  • Solitary, non-healing, enlarging or pigmented 'wart' in an older/immunosuppressed patient - exclude squamous cell carcinoma / verrucous carcinoma
  • Extensive, giant or atypical molluscum/warts - test for HIV/immunosuppression (giant molluscum-like lesions may be disseminated cryptococcosis/histoplasmosis)
  • Anogenital warts in a child - consider safeguarding/sexual abuse assessment
  • Rapidly growing anogenital lesion - exclude malignancy
  • Facial molluscum in HIV (marker of advanced disease)

Assessment

Differential diagnosis

  • Molluscum vs milia, closed comedones, basal cell carcinoma (solitary), cutaneous cryptococcosis/histoplasmosis (immunosuppressed, giant molluscum-like)
  • Wart vs corn/callus, actinic/seborrhoeic keratosis, squamous cell carcinoma (solitary, non-healing, in elderly/immunosuppressed)
  • Anogenital warts vs condylomata lata (secondary syphilis), molluscum, skin tags
  • Verrucous carcinoma (large recalcitrant plantar/anogenital lesion)

Investigations

  • Clinical diagnosis
  • Dermoscopy if uncertain (wart: thrombosed capillaries; molluscum: central umbilication)
  • Biopsy only if atypical, solitary, non-healing, pigmented or suspicious for malignancy
  • Immunosuppression/HIV screen if extensive, atypical, giant or treatment-resistant molluscum/warts
  • Anogenital lesions: full STI screen; cervical screening per programme; consider child safeguarding assessment for anogenital warts in a child

Management

  • Reassure: most cutaneous warts and molluscum in healthy people clear spontaneously (warts months-2 years; molluscum 6-18 months) - 'wait and watch' is reasonable, especially in children
  • Cutaneous warts: topical salicylic acid daily (+/- paring) and/or cryotherapy every 2-3 weeks if bothersome/persistent
  • Plantar/recalcitrant warts: combine salicylic acid, cryotherapy, occlusion; second-line formaldehyde/glutaraldehyde, intralesional options or referral
  • Molluscum: usually leave to self-resolve; avoid sharing towels/baths, do not scratch; treat only if bothersome (cryotherapy, topical agents) - avoid aggressive treatment in young children
  • Anogenital warts: topical podophyllotoxin or imiquimod, or cryotherapy/ablation; STI screen and partner notification; refer to GUM/genitourinary
  • Immunosuppressed with extensive/atypical lesions: treat underlying immunosuppression, dermatology/ID input, exclude malignancy
  • Encourage HPV vaccination for prevention of anogenital warts/cancer

Drugs & doses

Salicylic acid 11-50% topical wart paint/gel applied daily after paring/soaking for up to 12 weeks
Cryotherapy (liquid nitrogen) every 2-3 weeks for warts/molluscum [verify local]
Molluscum (if treated): topical options e.g. potassium hydroxide 5-10% solution, or cantharidin/cryotherapy per local availability [verify local]
Anogenital warts: podophyllotoxin 0.5% solution/cream applied twice daily for 3 days/week up to 4-5 weeks [verify local]
Imiquimod 5% cream applied three times weekly overnight, washed off after 6-10 h, up to 16 weeks (anogenital warts/molluscum) [verify local]
HPV vaccination for prevention (per national schedule)

Disposition

Community/GP management; most need only reassurance or simple topical therapy. Refer dermatology for recalcitrant, atypical or suspected malignant lesions; GUM/genitourinary for anogenital warts; immunosuppression/HIV workup and safeguarding assessment where indicated.

Complications & pitfalls

  • Spread (autoinoculation) and transmission to contacts
  • Molluscum dermatitis / secondary bacterial infection
  • Scarring from aggressive treatment (avoid in children)
  • Anogenital HPV: cervical/anal/oropharyngeal dysplasia and cancer (oncogenic types)
  • Psychological distress / cosmetic concern
  • Recalcitrant disease in immunosuppression

Exam pearls

  • Most cutaneous warts and molluscum self-resolve - reassurance and watchful waiting are appropriate, especially in children
  • Avoid aggressive/painful treatment of molluscum in young children - it is self-limiting
  • Extensive, giant or atypical molluscum/warts should prompt HIV/immunosuppression testing
  • A solitary, non-healing verrucous lesion in an older or immunosuppressed patient may be SCC - biopsy
  • Anogenital warts need STI screening and partner management; in children consider safeguarding
  • HPV vaccination prevents anogenital warts and HPV-related cancers - promote uptake

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.